ACD A 2.45 g/100mL

ACD A 2.45 g/100mL is an intravenous solution containing Citric Acid Monohydrate, Dextrose Monohydrate, and Trisodium Citrate Dihydrate. This solution is commonly used in medical settings for blood preservation and anticoagulation. ACD A 2.45 g/100mL is manufactured by Terumo BCT, Ltd. in the USA.

ACD A 2.45 g/100mL is primarily used for the preservation of blood and blood components during storage. It helps to prevent clotting and maintain the quality of blood products. This solution is often utilized in medical facilities for blood collection and transfusion purposes. The combination of citric acid, dextrose, and trisodium citrate in ACD A 2.45 g/100mL works together to ensure the stability and safety of stored blood.

When administered intravenously, ACD A 2.45 g/100mL helps to maintain the anticoagulant properties of the blood. It may cause a slight cooling sensation due to its composition. The solution is designed to be compatible with blood components, minimizing the risk of adverse reactions. Common effects include the prevention of blood clotting and the preservation of blood cells.

ACD A 2.45 g/100mL should be handled with care to avoid contamination. It is important to follow proper storage guidelines to maintain its effectiveness. The solution should be used under the supervision of a healthcare professional. Always check the packaging for any visible signs of damage or tampering before use.

ACD A 2.45 g/100mL may interact with certain medications or substances. It is advisable to consult with a healthcare provider before using this solution alongside other treatments. Avoid mixing with incompatible solutions to prevent adverse reactions. Always follow the manufacturer's guidelines for safe and effective use.